Drugs Made In America Acquisition II Corp.
- DMIIR
- NASDAQ
- Financial - Conglomerates
- SPAC Rights
- Blank Check Company
$0.08
Quote Oct 16, 2026, 08:00 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
−6.00%over the last month
Max drawdown −40.8%From 1-month high −6.0%3 months −0.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.1M
Quote Oct 16
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$0.08
4.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DMIIRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Financial - Conglomerates
Employees
2